1.
Tijdschr Psychiatr
; 65(2): 118-121, 2023.
Artículo
en Holandés
| MEDLINE
| ID: mdl-36912058
RESUMEN
We describe a 70 year old patient with a history of epilepsy, who developed a derealisation disorder after discontinuing the use of valproic acid. An experimental treatment with rTMS led to a remarkable decrease of his symptoms. We determined our target, the right ventrolateral prefrontal cortex (VLPFC), with the use of neuronavigation. During treatment no complications occurred, specifically no epileptic seizures.